San Francisco-based AKASA is transforming how healthcare providers manage their revenue cycles using AI. The company raised $85 million in Series B funding in July 2024, bringing its total capital raised to over $150 million. AKASA’s Unified Automation platform automates complex operational tasks, improving efficiency for hospitals and medical centres.
The company’s AI-driven solution integrates seamlessly with existing electronic health record (EHR) systems, helping healthcare organisations reduce administrative errors and optimise revenue cycles. This not only reduces costs but also allows healthcare providers to focus more on patient care.
“Our goal is to simplify the most complex, time-consuming aspects of revenue cycle management,” said Malinka Walaliyadde, co-founder and CEO of AKASA. “By leveraging AI, we can help healthcare providers reduce inefficiencies and make sure they get paid faster, which ultimately improves patient care”(Startup Savant).
Investors, including Bond and Andreessen Horowitz, have backed AKASA’s mission to revolutionise healthcare automation. “AKASA’s platform is a game-changer for healthcare providers. The ability to automate such complex tasks will not only save time and money but also enhance patient outcomes,” said a representative from Bond(Startup Savant).
